98-17548. Dow Corning Corp.; Filing of Food Additive Petition; Amendment  

  • [Federal Register Volume 63, Number 127 (Thursday, July 2, 1998)]
    [Notices]
    [Page 36246]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-17548]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 92F-0443]
    
    
    Dow Corning Corp.; Filing of Food Additive Petition; Amendment
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the filing 
    notice for a food additive petition filed by Dow Corning Corp. to 
    indicate that the petitioner has also proposed that the food additive 
    regulations be amended to provide for the safe use of 
    tetramethyltetravinylcyclotetrasiloxane as an optional polymerization 
    inhibitor in the manufacture of dimethylpolysiloxane coatings produced 
    by cross-linking a vinyl-containing dimethylpolysiloxane with 
    methylhydrogen-containing polysiloxane and dimethylmethylhydrogen 
    polysiloxane polymers using a platinum catalyst.
    
    FOR FURTHER INFORMATION CONTACT: Julius Smith, Center for Food Safety 
    and Applied Nutrition (HFS-215), Food and Drug Administration, 200 C 
    St. SW., Washington, DC 20204, 202-418-3091.
    
    SUPPLEMENTARY INFORMATION: In a notice published in the Federal 
    Register of February 12, 1993 (58 FR 8290), FDA announced that a 
    petition (FAP 3B4346) had been filed by Dow Corning Corp., P.O. Box 
    994, Midland, MI 48686-0994, proposing to amend Sec. 175.300 Resinous 
    and polymeric coatings (21 CFR 175.300), Sec. 175.320 Resinous and 
    polymeric coatings for polyolefin films (21 CFR 175.320), and 
    Sec. 176.170 Components of paper and paperboard in contact with aqueous 
    and fatty foods (21 CFR 176.170) to provide for the safe use of 
    dimethylpolysiloxane coatings produced by cross-linking a vinyl-
    containing dimethylpolysiloxane with methylhydrogen-containing 
    polysiloxane and dimethylmethylhydrogen polysiloxane polymers using a 
    platinum catalyst. The petition also proposed that the food additive 
    regulations be amended to provide for the safe use of 3,5-dimethyl-1-
    hexyne-3-ol, 1-ethynylcyclohexene, bis(methoxymethyl)ethyl maleate and 
    methylvinyl cyclosiloxane as optional polymerization inhibitors. 
    Additionally, the petition proposed that the regulations be amended to 
    provide for the safe use of 5-chloro-2-methyl-4-isothiazolin-3-one and 
    2-methyl-4-isothiazolin-3-one mixture, optionally containing magnesium 
    nitrate, as an antimicrobial agent for emulsion-based silicone coating 
    formulations.
        Subsequent to publication of the filing notice, the petitioner 
    amended the petition to request the use of 
    tetramethyltetravinylcyclotetrasiloxane as an optional polymerization 
    inhibitor in the manufacture of dimethylpolysiloxane coatings produced 
    by cross-linking a vinyl-containing dimethylpolysiloxane with 
    methylhydrogen-containing polysiloxane and dimethylmethylhydrogen 
    polysiloxane polymers using a platinum catalyst.
        Therefore, FDA is amending the filing notice of February 12, 1993, 
    to indicate that the petitioner requests that the food additive 
    regulations be amended to provide for the safe use of 
    tetramethyltetravinylcyclotetrasiloxane as an optional polymerization 
    inhibitor in the manufacture of dimethylpolysiloxane coatings produced 
    by cross-linking a vinyl-containing dimethylpolysiloxane with 
    methylhydrogen-containing polysiloxane and dimethylmethylhydrogen 
    polysiloxane polymers using a platinum catalyst.
        The agency has determined under 21 CFR 25.32(i) that this action is 
    of a type that does not individually or cumulatively have a significant 
    effect on the human environment. Therefore, neither an environmental 
    assessment nor an environmental impact statement is required.
    
        Dated: June 11, 1998.
    Laura M. Tarantino,
    Acting Director, Office of Premarket Approval, Center for Food Safety 
    and Applied Nutrition.
    [FR Doc. 98-17548 Filed 7-1-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
07/02/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
98-17548
Pages:
36246-36246 (1 pages)
Docket Numbers:
Docket No. 92F-0443
PDF File:
98-17548.pdf